Clinical Trial Update: ALTO-300 in Depression (ALTO-300-004) [Phase 2]

View source ↗

Summary

ALTO-300-004, a Phase 2 trial in Major Depressive Disorder, has completed enrollment and its study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ALTO-300

Snippet

Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED